Iht Wealth Management, LLC Viking Therapeutics, Inc. Transaction History

Iht Wealth Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.6 - $6.72 $55,199 - $80,640	-12,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.58 - $7.04 $5,580 - $7,040	1,000 Added 9.09%	12,000 $75,000
Q2 2021 Aug 16, 2021	SELL	$5.19 - $6.73 $11,418 - $14,806	-2,200 Reduced 16.67%	11,000 $66,000
Q1 2021 May 18, 2021	SELL	$5.74 - $9.67 $57,543 - $96,941	-10,025 Reduced 43.16%	13,200 $83,000
Q1 2019 May 16, 2019	SELL	$7.58 - $9.94 $758 - $994	-100 Reduced 0.43%	23,225 $231,000
Q4 2018 Feb 15, 2019	BUY	$7.16 - $16.21 $43,676 - $98,881	6,100 Added 35.41%	23,325 $178,000
Q3 2018 Nov 14, 2018	BUY	$9.7 - $19.65 $24,250 - $49,125	2,500 Added 16.98%	17,225 $300,000
Q2 2018 Aug 13, 2018	BUY	$3.88 - $12.74 $11,640 - $38,220	3,000 Added 25.59%	14,725 $140,000
Q4 2017 Feb 14, 2018	BUY	$1.74 - $4.34 $20,401 - $50,886	11,725	11,725 $60,000

480

66.2M

6.24M

3.01M

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $4.83B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Iht Wealth Management, LLC with notifications on news.